SCHEMBL7704656

SCHEMBL7704656

FC(F)(F)c1c[c]c(-c2cccs2)c(C(F)(F)F)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
KDM4E B2RXH2 7/20 0.36
L3MBTL1 Q9Y468 3/20 0.36
RXFP1 Q9HBX9 1/20 0.36
ALDH1A1 P00352 5/20 0.36
GAA P10253 2/20 0.36
CCNE2 O96020 1/20 0.36
CCNE1 P24864 1/20 0.36
CDK2 P24941 1/20 0.36
TDP1 Q9NUW8 3/20 0.35
MAPK1 P28482 2/20 0.35
MAPT P10636 2/20 0.35
PKM P14618 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
KMT2A Q03164 4/20 0.34
MEN1 O00255 3/20 0.34
ACHE P22303 1/20 0.34
LMNA P02545 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7705238 0.73 KIF11 (0.44) SMN1; SMN2KDM4EALDH1A1ACHE
SCHEMBL7702101 0.73 TOP1 (0.35) L3MBTL1GAACCNE2CCNE1CDK2
SCHEMBL28020018 0.72 ERN1 (0.41) ERN1SMN1; SMN2KDM4EL3MBTL1RXFP1
SCHEMBL11287914 0.71 NOTUM (0.43) MAPK1POLB
SCHEMBL7699851 0.70 BACE1 (0.31)
SCHEMBL7704880 0.69 KDM4E (0.33) SMN1; SMN2KDM4EALDH1A1GAAMAPT
SCHEMBL7705819 0.69 CFTR (0.38) SMN1; SMN2KDM4EALDH1A1GAAMAPT
SCHEMBL7704658 0.68 ERN1 (0.40) ERN1SMN1; SMN2KDM4EL3MBTL1RXFP1
SCHEMBL8995621 0.68 CES2 (0.31)
SCHEMBL7701994 0.68 CYP11B1 (0.36) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242399-A1 $g(a)-ARYLETHYLPIPERAZINE DERIVATIVES AS NEUROKININ ANTAGONISTS UCB S.A. (BE) 2002-09-25 EP disclosed
WO-2001046167-A1 α-ARYLETHYLPIPERAZINE DERIVATIVES AS NEUROKININ ANTAGONISTS UCB, S.A. (BE) 2001-06-28 WO disclosed